// App-Quantinova.ai

29033 : THREEYEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE v EVEROLIMUSELUTING STENTS

Researchers

Presenter

  • Gregg W. Stone

Principal Investigators

  • Paul Teirstein

  • Ian Meredith

  • Dominic J. Allocco

  • Keith D. Dawkins

  • Robert Stoler

  • Abram Rabinowitz

  • Vincent Pompili

  • Ameer Kabour

  • Thomas Stuckey

  • Nick Curzen

  • Shigeru Saito

  • Andrejs Erglis

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Boston Scientific

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary artery lesions

  • Chronic total occlusion

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim